Key Financial Data Of Group

Perseus Proteomics Inc. - Filing #7603610

Concept As at
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2019-03-31
2018-04-01 to
2019-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
Key financial data of group
Business results of group
Net sales
71,932,000 JPY
67,947,000 JPY
85,759,000 JPY
275,959,000 JPY
303,983,000 JPY
Ordinary profit (loss)
-481,681,000 JPY
-410,107,000 JPY
-834,362,000 JPY
-145,545,000 JPY
-163,663,000 JPY
Net assets
3,152,154,000 JPY
1,083,713,000 JPY
485,889,000 JPY
1,327,621,000 JPY
1,490,676,000 JPY
Total assets
3,300,530,000 JPY
1,118,626,000 JPY
547,889,000 JPY
1,360,169,000 JPY
1,514,980,000 JPY
Net assets per share
268.05
128.86
79.05
216.00
7,275.85
Basic earnings (loss) per share
-54.47
-59.03
-136.95
-26.53
-2,072.47
Diluted earnings per share
Equity-to-asset ratio
0.9550 xbrli:pure
0.9661 xbrli:pure
0.8868 xbrli:pure
0.9761 xbrli:pure
0.9840 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-476,842,000 JPY
-422,836,000 JPY
-608,524,000 JPY
-329,661,000 JPY
-132,356,000 JPY
Net cash provided by (used in) investing activities
-33,868,000 JPY
-2,824,000 JPY
-3,409,000 JPY
-15,945,000 JPY
10,647,000 JPY
Net cash provided by (used in) financing activities
2,647,548,000 JPY
1,011,040,000 JPY
JPY
JPY
1,395,040,000 JPY
Cash and cash equivalents
3,214,852,000 JPY
1,069,300,000 JPY
482,464,000 JPY
1,100,128,000 JPY
1,449,016,000 JPY
Number of employees
21 xbrli:pure
19 xbrli:pure
21 xbrli:pure
23 xbrli:pure
20 xbrli:pure
Average number of temporary employees
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.